Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02316197. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neopl
ClinicalTrials.gov study NCT06303193. IPD Sharing: YES. Countries: 1. Publications: 1.
Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients
ClinicalTrials.gov study NCT03382795. IPD Sharing: Not stated. Countries: 1. Publications: 18.
Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory Study
ClinicalTrials.gov study NCT01190241. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02228369. IPD Sharing: YES. Countries: 4. Publications: 2.
Assessment of Serum Levels of Janus Kinase 1 and 2 in Patients With Cholinergic Urticaria
ClinicalTrials.gov study NCT06201780. IPD Sharing: Not stated. Countries: 1. Publications: 4.
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors
ClinicalTrials.gov study NCT02146222. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02206763. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pyruvate Kinase Isoform M2 (PKM2) as a Possible Biomarker for Cancer
ClinicalTrials.gov study NCT01130584. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Therapeutic Resistance Prediction of Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT02851329. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
The Safety, Pharmacokinetic and Pharmacodynamic Effect of KA2237 (PI3 Kinase p110β/δ Inhibitor) In B Cell Lymphoma
ClinicalTrials.gov study NCT02679196. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata
ClinicalTrials.gov study NCT05861401. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04009317. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma
ClinicalTrials.gov study NCT01968928. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency
ClinicalTrials.gov study NCT06754098. IPD Sharing: NO. Countries: 1. Publications: 4.
Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma
ClinicalTrials.gov study NCT04331041. IPD Sharing: YES. Countries: 1. Publications: 1.
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
ClinicalTrials.gov study NCT06174220. IPD Sharing: NO. Countries: 1. Publications: 5.
Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT03647956. IPD Sharing: UNDECIDED. Countries: 1. Publications: 21.
Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors
ClinicalTrials.gov study NCT01138033. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Pyruvate Kinase Deficiency Global Longitudinal Registry
ClinicalTrials.gov study NCT03481738. IPD Sharing: UNDECIDED. Countries: 16. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.